Bill Snyder

“Safety Pharmacology” will be the topic of the 23rd annual Joel G. Hardman Student-Invited Pharmacology Forum Tuesday, March 18, in 202 Light Hall. Read More

Vanderbilt University scientists have found evidence that the insulin-secreting beta cells of the pancreas, which are either killed or become dysfunctional in the two main forms of diabetes, have the capacity to regenerate. Read More

Vanderbilt University researchers are collaborating in a multi-center, federally-funded project to develop ways to treat and prevent the highly lethal Ebola and Marburg virus infections. Read More

“There has never been a time when we need leaders more than today.” With these words, Jeff Balser, M.D., Ph.D., vice chancellor for Health Affairs and dean of the School of Medicine, began his quarterly conversation with colleagues at Wednesday’s Clinical Enterprise Leadership Assembly in Langford Auditorium. Read More

An international group led by Vanderbilt University researchers has found cannabinoid receptors, through which marijuana exerts its effects, in a key emotional hub in the brain involved in regulating anxiety and the flight-or-fight response. Read More

Vanderbilt University has been awarded a Cooperative Agreement with the Defense Advanced Research Projects Agency and the Army Research Office that is worth up to $16.5 million over five years. Read More

Vanderbilt University’s Craig Lindsley, Ph.D., has won the 2014 John J. Abel Award in Pharmacology for young investigators from the American Society for Pharmacology and Experimental Therapeutics (ASPET). Read More

“Brain Blast,” a half day of free, hands-on activities for children and adults, will be held from 9 a.m. to 1 p.m., Saturday, March 1, at Vanderbilt Health One Hundred Oaks, 719 Thompson Lane. Read More

Richard Kim, M.D., former professor of Medicine and clinical pharmacologist at Vanderbilt, will deliver this year’s Grant R. Wilkinson Distinguished Lecture in Clinical Pharmacology at 8 a.m. Thursday, Feb. 27, in 208 Light Hall. Read More

Vanderbilt University Medical Center has received an 18-month, $6.9 million award to set up a Clinical Data Research Network (CDRN) that can reach millions of patients and speed the translation of research findings into clinical practice. Read More

Ron Vale, Ph.D., co-discoverer of the molecular “motor” kinesin, spent the first 10 minutes of his Flexner Discovery Lecture last week talking not about science, but about science communication. Read More

The antioxidant vitamin E prevented the buildup of toxic products in a model of a rare genetic disorder, suggesting new strategies for therapeutic development. Read More

Vanderbilt University scientists have contributed to a major finding, reported this week in the journal Nature, which could lead to the first effective vaccine against respiratory syncytial virus (RSV), a significant cause of infant mortality. Read More

Vanderbilt University’s AIDS Clinical Trials Unit (ACTU) has received a seven-year grant renewal from the National Institutes of Health (NIH). Read More

Colleen Niswender, Ph.D., research associate professor of Pharmacology, has received a three-year, $450,000 grant from the autism science and advocacy organization Autism Speaks to support studies investigating a possible new treatment for Rett syndrome. Read More

Ron Vale, Ph.D., Lasker Award winner and co-discoverer of the molecular “motor” kinesin, will give the next Flexner Discovery Lecture at 4 p.m. on Thursday, Jan. 30, in 208 Light Hall. Read More

Vanderbilt University researchers have discovered a “backdoor” approach to blocking an enzyme that fuels the growth of glioblastoma, the most common and most fatal form of brain cancer. Read More

Krassimira Garbett, Ph.D., Patricia “Cookie” Minton, R.N., and Kent Shaddox are the recipients of the 2013 Research Staff Awards at Vanderbilt University Medical Center. Read More

Beyond genetics — that’s the call Oliver McDonald, M.D., Ph.D., heard during the year between college and medical school he spent in a lab at St. Jude Children’s Research Hospital in Memphis. Read More

A chemical bond discovered by Vanderbilt University scientists that is essential for animal life and which hastened the “dawn of the animal kingdom” could lead to new therapies for cancer and other diseases. Read More